← Evidence map

ArticleImmune network2026

Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease.

Arun Meas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Intranasal Delivery of an RSV A2-Derived Pre-F VLP Vaccine Induces Robust Mucosal and Systemic Immunity Against RSV B Strain Without Enhanced Disease. | Socratic